Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Innovent Biopharmaceutical Technology (hangzhou) Co., Ltd.

Clinical trials sponsored by Innovent Biopharmaceutical Technology (hangzhou) Co., Ltd., explained in plain language.

Now part of Innovent Biologics, Inc. 1801 HKEX

A biopharmaceutical company developing and commercializing innovative medicines.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 6 Not yet finished but already full! 1

New hope for psoriasis patients when first treatment fails

Disease control Ongoing

This study tests a new medicine called picankibart for people with plaque psoriasis who did not improve enough after using standard IL-17 antibody treatments. About 308 adults in China will take part. The goal is to see if switching to picankibart can clear or nearly clear the sk…

Phase: PHASE3 • Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. • Aim: Disease control

Last updated Jun 27, 2026 12:00 UTC